Home
    Disclaimer

    3,4-Dichloromethylphenidate Stats & Data

    3,4-ctmp 3,4-dcmp Dichloromethylphenidate 34ctmp
    PubChem
    MW302.2
    FormulaC14H17Cl2NO2
    LogP1.5
    IUPACmethyl (2R)-2-(3,4-dichlorophenyl)-2-[(2R)-piperidin-2-yl]acetate
    InChIKeyJUKMAYKVHWKRKY-CHWSQXEVSA-N
    Psychoactive Class Stimulant

    Pharmacology

    DrugBank

    Receptor Profile

    Receptor Actions

    Agonists
    5-HT2B receptor agonist
    Inhibitors
    Dopamine reuptake inhibitor
    Norepinephrine reuptake inhibitor

    Toxicity

    PsychonautWiki

    The toxicity and long-term health effects of recreational 3,4-CTMP use do not seem to have been studied in any scientific context, and the exact toxic dosage is unknown. This is because 3,4-CTMP is a research chemical with very little history of human usage. Although anecdotal evidence from people who have tried 3,4-CTMP suggests that there are unlikely to be negative health effects attributed to simply trying the substance by itself at low to moderate doses, the agonist activity it displays for the 5-HT2B receptor is a cause for concern, as acute 5-HT2B agonism has been shown to result in a potentially dangerous and largely asymptomatic effect called pulmonary hypertension.

    Effect Profile

    Curated + 5 Reports
    Stimulant 6.4

    Strong anxiety/jitters, euphoria, and focus with mild stimulation

    Stimulation / Energy×3
    5
    Euphoria / Mood Lift×2
    9
    Focus / Productivity×2
    9
    Anxiety / Jitters×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1d Half tolerance 10d Baseline ~18d

    Experience Report Analysis

    Erowid
    5 Reports
    2014–2019 Date Range
    5 With Age Data
    4 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 5 experience reports (5 Erowid)

    5 Reports
    4 Effects Detected
    2 Positive
    1 Adverse
    1 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 2

    Focus Enhancement 80.0% 70%
    Stimulation 80.0% 70%

    Adverse Effects 1

    Increased Heart Rate 100.0% 70%

    Real-World Dose Distribution

    62K Doses

    From 14 individual dose entries

    Oral (n=7)

    Median: 5.0mg 25th: 5.0mg 75th: 5.5mg 90th: 6.0mg
    mg/kg median: 0.068 mg/kg 75th: 0.084

    Insufflated (n=6)

    Median: 6.5mg 25th: 6.0mg 75th: 7.0mg 90th: 9.5mg
    mg/kg median: 0.096 mg/kg 75th: 0.102

    Form / Preparation

    Most common forms and preparations reported

    ← Back to 3,4-Dichloromethylphenidate